IL17A and systemic lupus erythematosus: SLE-associated nephritis is a common and serious complication in SLE patients, and IL-17-producing DN T cell infiltration is positively correlated with kidney disease progression in SLE patients and murine lupus models, suggesting that DN T cells might be a biomarker as well as a therapeutic target for lupus nephritis (9, 81–83).